)
)
)
Polypid, Ltd.
PolyPid (NASDAQ: PYPD) a late-stage biopharma company with a post-Phase 3 asset, aiming to improve surgical outcomes by delivering locally administered, controlled, prolonged-release therapeutics for a period of several day to months.
Address
NutleyNJ
United States
)
){kind=logo}
)
){kind=logo}
){kind=logo}
)
)
)
)